Alfred Uppal

DNP Doctor of Nursing Practice,  Toronto General - University Health Network 

Location: Africa

Consulting Services

Sales and Marketing Grant Submission Journal Manuscript

Areas Of Interest

Fruits, Miracle Human Glandular Kallikrein 2 Cancers, Pulmonary Drugs, Hypolipidemic Mangabeys C1r Complement Mesencephalic Neoplasms Heterotrophic Process Cystatin SA I Transfer RNA, Val Health Plan, Accountable Clinical Enzyme Tests Absorption, Physicochemical Perception Corrections, Auditory Service, Pharmaceutic B Cell Progenitor Kinase Suit, Pressure RNA Stability Platelet alpha-Granule Deficiencies Sensitivity Modulating Protein Human poliovirus 2 Medicine Chests beta Lactamase RP4 Diagnosis, Preimplantation X Linked Mental Retardation Classic Pelizaeus-Merzbacher Disease Neoplasms, Hypothalamic-Pituitary Brazilian Box Trees DNA, B Form Acid, Rhetinic cGMP Dependent Protein Kinase 2 Ideomotor Apraxia National Institute on Alcohol Abuse and Alcoholism Service, Advisory Low Power Laser Therapy Ethics Committee, Institutional Serum Response Factor Like Protein 1

Professional Narrative

Dr. Alfred Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Amgen 1996
Senior Director, Mayo Clinic 2000

Education

Bachelor of science in nursing, Weill Medical College 1995
Director Medicine, Yale School of Medicine 2009

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Hou X, Zaks T, Langer R, Dong Y. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078-1094. doi: 10.1038/s41578-021-00358-0. Epub 2021 Aug 10. PMID: 34394960; PMCID: PMC8353930.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :